200 new life science jobs added to Cook Pharmica’s $80 million dollar expansion program
BLOOMINGTON, Ind. The city of Bloomington and its politicians were praising the announcement of an 80,000 sq. ft. expansion for Cook Pharmica, the biopharmaceutical contract manufacturing division of Cook Medical. Cook is said to be investing $80 million in the expansion and adding 200 jobs—including professional, hourly and management employees.
Construction for the expansion is set to begin mid-2008, and be completed in early 2010. The plans include creating two filling lines and complementary finishing lines, as well as one high-speed syringe filling line and one low- to medium-speed vial filling line with lyophilization capacity up to 250 sq. ft. Both lines will feature isolator technology.
“We could not be more thrilled with the acceptance we have gained from our customers and everyone involved that has made this expansion possible, which we have named Project Eos—the Greek goddess of the dawn,” said Jerry Arthur, president of Cook Pharmica. “This expansion, which further diversifies our expansive portfolio of services, marks the dawn of a new era in our company’s growth, and is a testament to Cook’s commitment to contract biopharmaceutical manufacturing.”
The expansion also ensures that Cook Pharmica will offer its customers formulation, filling and finishing services.
Cook Medical is said to be a rising international business—Cook Urological also saw an expansion in Spencer, Ind., and a new office and warehouse will open this year in Shanghai, China.
Among its capabilities, the company offers cell line/strain development, clone selection, cell line adaptation, media optimization, process development, analytical development, cell banking/storage, stability testing/storage and regulatory submission support.
Parata launches PACMED C30 packaging technology
DURHAM, N.C. Parata Systems has launched its new product, the PACMED C30, which is a packaging technology used to extend the safety and convenience of its onePAC packaging system.
onePac is a strip that contains information like patients’ medications, patient names, pill descriptions and time of day to take a dose of the medication. On the strip, up to 19 lines of information can be held. The goal of the strips are to remind patients who take multiple medications when to take what medications and how much of each medication.
The PACMED C30 expands on the technology of the onePAC by combining multiple onePAC strips together for easy access by patients. PACMED C30 is efficient and accurate, generating up to 60 unit-dose or 50 multi-dose packages a minute.
“Adherence is a critical touch point in the circle of pharmacy care, and Parata’s launch of PACMED C30 offers an exciting new way for pharmacies to extend their care by improving patient adherence, safety and convenience,” says Tom Rhoads, executive vice president for customer and market strategies at Parata Systems.
Teva announces availablility of generic Fosamax
NORTH WALES, Pa. Teva has announced the introduction and availability of alendronate sodium tablets.
This is the generic version of the osteoporosis drug Fosamax by Merck. The drug will be available in 5 mg, 10 mg, 35 mg, 40 mg and 70 mg strengths.
“Our customers count on Teva for a continuous supply of new generic products,” stated John Denman, vice president of sales and marketing. “With the launch of alendronate sodium tablets, we add another quality product to our broad line of affordable generic pharmaceuticals.”